Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens

Several point-of-care (POC) molecular tests have received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The test performance characteristics of the Accula (Mesa Biotech) SARS-CoV-2 POC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, Catherine A., Garamani, Natasha, Lee, Andrew S., Tung, Jack K., Sahoo, Malaya K., Huang, ChunHong, Stevens, Bryan, Zehnder, James, Pinsky, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383558/
https://www.ncbi.nlm.nih.gov/pubmed/32461285
http://dx.doi.org/10.1128/JCM.01072-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383558/
https://www.ncbi.nlm.nih.gov/pubmed/32461285
http://dx.doi.org/10.1128/JCM.01072-20

Ejemplares similares